home · filing · 0001157523-23-000853
8-K
filed May 16, 2023, 7:59 PM ET
ticker MOH
CIK 0001179929
leadership
confidence high
sentiment positive
materiality 0.60
Molina Healthcare promotes Jim Woys to COO, Mark Keim remains CFO with expanded role
MOLINA HEALTHCARE, INC.
Jim Woys promoted to senior executive VP and COO, effective May 15, 2023.
Mark Keim promoted to senior executive VP, continues as CFO with expanded operational and growth responsibilities.
Woys had served as EVP health plan services since 2018; Keim was EVP transformation and became CFO in Feb 2021.
No changes to compensation incidental to the promotions.
CEO Joe Zubretsky says both instrumental in Molina's growth over past five years.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-05-15
Filed May 16, 2023, 7:59 PM ET
Mr. Keim will continue as the Company’s chief financial officer with expanded operational and growth-related responsibilities
Effective 2023-05-15
Filed May 16, 2023, 7:59 PM ET
Mr. Woys assumed the role of the Company’s chief operating officer
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Keim changed role as chief financial officer at MOLINA HEALTHCARE, INC..
Action promoted
Role chief financial officer
Exact text from the filing
Mr. Keim will continue as the Company’s chief financial officer with expanded operational and growth-related responsibilities
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jim Woys changed role as chief operating officer at MOLINA HEALTHCARE, INC..
Action promoted
Role chief operating officer
Exact text from the filing
Mr. Woys assumed the role of the Company’s chief operating officer
View on SEC.gov
Source: SEC EDGAR
accession 0001157523-23-000853
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.